Du Meng

Metformin suppresses HIF‐1α expression in cancer‐associated fibroblasts to prevent tumor‐stromal cross talk in breast cancer

Qian Ning, Xinhan Zhao, D. Meng, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.

Xinhan Zhao, D. Meng, Lifeng Liu, 2015, Oncology reports.

Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells

Xinhan Zhao, Min Meng, D. Meng, 2018, Journal of Cancer Research and Clinical Oncology.

Primary Ewing's sarcoma of vulva: A case report and a review of the literature

D. Meng, S. Che, Pei Cao, 2013, The journal of obstetrics and gynaecology research.

A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells

R. Liu, H. Lei, D. Meng, 2019, OncoTargets and therapy.

GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway

P. Hou, D. Meng, C. Dang, 2022, Cell Death & Disease.

VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.

Xinhan Zhao, D. Meng, Lifeng Liu, 2016, Cancer letters.

Selective colorectal cancer cell lysates enhance the immune function of mature dendritic cells in vitro.

D. Meng, Lei Zhao, Lihong Chen, 2015, Molecular medicine reports.

A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation

D. Meng, Xiaozhi Zhang, Suxia Han, 2017, Oncotarget.

MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells

Xiaozhi Zhang, Dongli Zhao, Yunyi Yang, 2018, OncoTargets and therapy.